Norovirus co-opts NINJ1 for selective protein secretion
Science Advances · 28.02.2025 · 11 (9)
DOI: 10.1126/sciadv.adu7985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 28.02.2025. Verfasst von Jaewon Song und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Norovirus, Caliciviridae Infections, Viral Nonstructural Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Plasma membrane rupture by Ninjurin-1 (NINJ1) executes programmed cell death, releasing large cellular damage-associated molecular patterns (DAMPs). However, the regulation and selectivity of NINJ1-mediated DAMP release remain unexplored. Here, we uncover that murine norovirus (MNoV) strategically co-opts NINJ1 to selectively release the intracellular viral protein NS1, while NINJ1-mediated plasma membrane rupture simultaneously bulk-releases various cellular DAMPs. Host caspase-3 cleaves the precursor NS1/2, leading to NS1 secretion via an unconventional pathway. An unbiased CRISPR screen identifies NINJ1 as an essential factor for NS1 secretion. During infection, NINJ1 is recruited to the viral replication site, where it oligomerizes and forms speckled bodies, directly interacting with NS1. Subsequent mutagenesis studies identify critical amino acid residues of NS1 necessary for its interaction with NINJ1 and selective secretion. Genetic ablation or pharmaceutical inhibition of caspase-3 inhibits oral MNoV infection in mice. This study underscores the co-option of NINJ1 for controlled release of an intracellular viral protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA.
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Center for Computational Biology of Human Disease and Center for Computation and Visualization, Brown University, Providence, RI 02912, USA.
- Department of Laboratory Medicine, Yale University, New Haven, CT 06520, USA.
- Department of Immunobiology, Yale University, New Haven, CT 06520, USA.
ORCID-Profile: Jaewon Song, Seokoh Moon, Ariana Fang, Guoxun Wang, Newsha Gheshm, Skylar A Loeb, Joselynn R Wallace, Mia Madel Alfajaro, Madison S Strine, Wandy L Beatty, Amanda M Jamieson, Bridget A Robinson, Timothy J Nice, Craig B Wilen, Tiffany A Reese, Sanghyun Lee
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Song, J., Zhang, L., Moon, S., Fang, A., Wang, G., Gheshm, N., Loeb, S. A., Cao, P., Wallace, J. R., Alfajaro, M. M., Strine, M. S., Beatty, W. L., Jamieson, A. M., Orchard, R. C., Robinson, B. A., Nice, T. J., Wilen, C. B., Orvedahl, A., Reese, T. A., & Lee, S. (2025). Norovirus co-opts NINJ1 for selective protein secretion. Science Advances, 11(9). https://doi.org/10.1126/sciadv.adu7985
Vancouver
Song J, Zhang L, Moon S, Fang A, Wang G, Gheshm N, et al. Norovirus co-opts NINJ1 for selective protein secretion. Science Advances. 2025;11(9). doi:10.1126/sciadv.adu7985
BibTeX
@article{Song2025,
author = {Song, Jaewon and Zhang, Li and Moon, Seokoh and Fang, Ariana and Wang, Guoxun and Gheshm, Newsha and Loeb, Skylar A and Cao, Paul and Wallace, Joselynn R and Alfajaro, Mia Madel and Strine, Madison S and Beatty, Wandy L and Jamieson, Amanda M and Orchard, Robert C and Robinson, Bridget A and Nice, Timothy J and Wilen, Craig B and Orvedahl, Anthony and Reese, Tiffany A and Lee, Sanghyun},
title = {Norovirus co-opts NINJ1 for selective protein secretion},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {9},
doi = {10.1126/sciadv.adu7985}
}
EUVIMED